Mkts

Supernus Pharmaceuticals, Inc.

NASDAQ: SUPN
$27.62+1.46 (+5.58%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
26.1127.91
52-week range
25.9259.68
Today
Open27.05
Previous close27.62
Volume—
Valuation
Market cap5.43B
P/E ratio15.80×
EPS (TTM)2.73
Income & risk
Dividend / yield—
Beta0.66
Avg volume1.22M
Discussion

SUPN News

Stories mentioning SUPN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue207,705211,572192,103165,453149,824174,159175,689168,325
Cost of Goods Sold23,39123,00718,96516,82715,76326,09817,58317,916
Gross Profit184,314188,565173,138148,626134,061148,061158,106150,409
Operating Expenses
Research & Development39,43827,82729,36622,11526,92728,64729,03626,183
Sales General & Admin125,173122,390179,67893,55189,94479,40969,75385,904
Total Operating Expenses
Operating Income (Loss)(8,332)(3,937)(60,231)12,141(10,256)21,40540,84522,569
Interest Income
Interest Expense
Other Expense2,3822,0232,2774,5284,4254,9774,0983,733
Pretax Income(5,950)(1,914)(57,954)16,669(5,831)26,38244,94326,302
Tax Provision(3,657)2,191(12,837)(5,830)5,99611,0546,4466,386
Net Income (Loss)(2,293)(4,105)(45,117)22,499(11,827)15,32838,49719,916
Earnings Per Share (Basic)(0.04)(0.07)(0.80)0.40(0.21)0.280.700.36
Earnings Per Share (Diluted)(0.04)(0.07)(0.80)0.40(0.21)0.270.690.36
Weighted Average Shares Outstanding (Basic)57,64856,45156,55356,02555,86555,10055,15054,979
Weighted Average Shares Outstanding (Diluted)57,64856,45156,55356,64355,86555,95956,01655,724

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SUPN

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) is a stock listed on the Nasdaq Stock Market under the ticker symbol SUPN. It last traded at $27.62 (Nov 9, 2026, 4:00 PM ET), up 5.6% on the day. That gives Supernus Pharmaceuticals a market capitalisation of $5.4B and a price-to-earnings ratio of 15.8.

Over the past 52 weeks SUPN has traded between $25.92 and $59.68.

Revenue for the quarter ended Mar 31, 2026 was $207.7M; a net loss of $2.3M. Revenue was up 38.6% from $149.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$207.7M-$2.3M-1.1%
Dec 31, 2025$211.6M-$4.1M-1.9%
Sep 30, 2025$192.1M-$45.1M-23.5%
Jun 30, 2025$165.5M$22.5M13.6%

From Supernus Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…